ANI Pharmaceuticals, Inc. BSFA.SG Stock
ANI Pharmaceuticals, Inc. Price Chart
ANI Pharmaceuticals, Inc. BSFA.SG Financial and Trading Overview
ANI Pharmaceuticals, Inc. stock price | 62.5 EUR |
Previous Close | 44.6 EUR |
Open | 45.4 EUR |
Bid | 45.2 EUR x 150000 |
Ask | 47.6 EUR x 150000 |
Day's Range | 45.4 - 45.4 EUR |
52 Week Range | 21.6 - 45.4 EUR |
Volume | 0 EUR |
Avg. Volume | 4 EUR |
Market Cap | 945.69M EUR |
Beta (5Y Monthly) | 1.027464 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0.79 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
BSFA.SG Valuation Measures
Enterprise Value | 981.67M EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.6364844 |
Price/Book (mrq) | 2.3927479 |
Enterprise Value/Revenue | 2.737 |
Enterprise Value/EBITDA | 15.222 |
Trading Information
ANI Pharmaceuticals, Inc. Stock Price History
Beta (5Y Monthly) | 1.027464 |
52-Week Change | 109.25% |
S&P500 52-Week Change | 20.43% |
52 Week High | 45.4 EUR |
52 Week Low | 21.6 EUR |
50-Day Moving Average | 37.7 EUR |
200-Day Moving Average | 37.04 EUR |
BSFA.SG Share Statistics
Avg. Volume (3 month) | 4 EUR |
Avg. Daily Volume (10-Days) | 4 EUR |
Shares Outstanding | 20.15M |
Float | 12.29M |
Short Ratio | N/A |
% Held by Insiders | 13.51% |
% Held by Institutions | 73.43% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -7.34% |
Operating Margin (ttm) | 1.30% |
Gross Margin | 60.35% |
EBITDA Margin | 17.97% |
Management Effectiveness
Return on Assets (ttm) | 0.38% |
Return on Equity (ttm) | -7.67% |
Income Statement
Revenue (ttm) | 358.69M EUR |
Revenue Per Share (ttm) | 21.97 EUR |
Quarterly Revenue Growth (yoy) | 65.60% |
Gross Profit (ttm) | 177.6M EUR |
EBITDA | 64.49M EUR |
Net Income Avi to Common (ttm) | -28066000 EUR |
Diluted EPS (ttm) | -1.6 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 67.76M EUR |
Total Cash Per Share (mrq) | 4.09 EUR |
Total Debt (mrq) | 286.31M EUR |
Total Debt/Equity (mrq) | 84.34 EUR |
Current Ratio (mrq) | 2.899 |
Book Value Per Share (mrq) | 18.974 |
Cash Flow Statement
Operating Cash Flow (ttm) | 9.16M EUR |
Levered Free Cash Flow (ttm) | 15.99M EUR |
Profile of ANI Pharmaceuticals, Inc.
Country | Germany |
State | MN |
City | Baudette |
Address | 210 Main Street West |
ZIP | 56623 |
Phone | 218 634 3500 |
Website | https://www.anipharmaceuticals.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 600 |
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations, including extended release and combination products. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Q&A For ANI Pharmaceuticals, Inc. Stock
What is a current BSFA.SG stock price?
ANI Pharmaceuticals, Inc. BSFA.SG stock price today per share is 62.5 EUR.
How to purchase ANI Pharmaceuticals, Inc. stock?
You can buy BSFA.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ANI Pharmaceuticals, Inc.?
The stock symbol or ticker of ANI Pharmaceuticals, Inc. is BSFA.SG.
Which industry does the ANI Pharmaceuticals, Inc. company belong to?
The ANI Pharmaceuticals, Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does ANI Pharmaceuticals, Inc. have in circulation?
The max supply of ANI Pharmaceuticals, Inc. shares is 20.98M.
What is ANI Pharmaceuticals, Inc. Price to Earnings Ratio (PE Ratio)?
ANI Pharmaceuticals, Inc. PE Ratio is 79.11392000 now.
What was ANI Pharmaceuticals, Inc. earnings per share over the trailing 12 months (TTM)?
ANI Pharmaceuticals, Inc. EPS is 0.79 EUR over the trailing 12 months.
Which sector does the ANI Pharmaceuticals, Inc. company belong to?
The ANI Pharmaceuticals, Inc. sector is Healthcare.